Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator
Gespeichert in:
| Veröffentlicht in: | Therapeutic apheresis and dialysis 2020-10, Vol.24 (5), p.602-606 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 606 |
|---|---|
| container_issue | 5 |
| container_start_page | 602 |
| container_title | Therapeutic apheresis and dialysis |
| container_volume | 24 |
| creator | Daimon, Shoichiro |
| description | |
| doi_str_mv | 10.1111/1744-9987.13537 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2414009559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2414009559</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3677-618d72dea3ee720bc683f0aa92e8b9163d50034fdaf70ab3e8ac7bb6e033f5743</originalsourceid><addsrcrecordid>eNqFkE9PwyAYh4nRuDk9ezMcvXSjpS3tcVn8lyxxh3kmlL7NMG2pwFz6Bfzc0nXuKgd4gef9BR6E7kMyD_1YhCyOgzzP2DykCWUXaHo-uTzXLJ-gG2s_CYmimNJrNKGRhzMWT9HPRlurihqw0X7SFW5By97purfKYtVi0UKjxFDtoNGlEuNNJ5yC1ll8UG6HS2EK6DS4oaGuBNYGS9367V7vLQbTu53RnVZHwoCEznlESKe-ha9u0VUlagt3p3WGPp6ftqvXYP3-8rZargNJU8aCNMxKFpUgKACLSCHTjFZEiDyCrMjDlJYJITSuSlExIgoKmZCsKFIglFYJi-kMPY65ndFfe7CON8pKqGv_S_9QHsVhTEieJLlHFyMqjVdkoOKdUY0wPQ8JH-TzQS8fVPOjfN_xcArfFw2UZ_7PtgeSETioGvr_8vh2uRmDfwHhlJL3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414009559</pqid></control><display><type>article</type><title>Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Daimon, Shoichiro</creator><creatorcontrib>Daimon, Shoichiro</creatorcontrib><identifier>ISSN: 1744-9979</identifier><identifier>EISSN: 1744-9987</identifier><identifier>DOI: 10.1111/1744-9987.13537</identifier><identifier>PMID: 32537874</identifier><language>eng</language><publisher>Kyoto, Japan: John Wiley & Sons Australia, Ltd</publisher><subject>Aged ; Anemia - complications ; Anemia - drug therapy ; Anemia - physiopathology ; Darbepoetin alfa - therapeutic use ; Erythropoietin - therapeutic use ; Female ; Hematinics - therapeutic use ; Homeostasis ; Humans ; Male ; Polyethylene Glycols - therapeutic use ; Renal Dialysis ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - therapy</subject><ispartof>Therapeutic apheresis and dialysis, 2020-10, Vol.24 (5), p.602-606</ispartof><rights>2020 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3677-618d72dea3ee720bc683f0aa92e8b9163d50034fdaf70ab3e8ac7bb6e033f5743</citedby><cites>FETCH-LOGICAL-c3677-618d72dea3ee720bc683f0aa92e8b9163d50034fdaf70ab3e8ac7bb6e033f5743</cites><orcidid>0000-0001-9399-7433</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1744-9987.13537$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1744-9987.13537$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32537874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Daimon, Shoichiro</creatorcontrib><title>Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator</title><title>Therapeutic apheresis and dialysis</title><addtitle>Ther Apher Dial</addtitle><subject>Aged</subject><subject>Anemia - complications</subject><subject>Anemia - drug therapy</subject><subject>Anemia - physiopathology</subject><subject>Darbepoetin alfa - therapeutic use</subject><subject>Erythropoietin - therapeutic use</subject><subject>Female</subject><subject>Hematinics - therapeutic use</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Male</subject><subject>Polyethylene Glycols - therapeutic use</subject><subject>Renal Dialysis</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - therapy</subject><issn>1744-9979</issn><issn>1744-9987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE9PwyAYh4nRuDk9ezMcvXSjpS3tcVn8lyxxh3kmlL7NMG2pwFz6Bfzc0nXuKgd4gef9BR6E7kMyD_1YhCyOgzzP2DykCWUXaHo-uTzXLJ-gG2s_CYmimNJrNKGRhzMWT9HPRlurihqw0X7SFW5By97purfKYtVi0UKjxFDtoNGlEuNNJ5yC1ll8UG6HS2EK6DS4oaGuBNYGS9367V7vLQbTu53RnVZHwoCEznlESKe-ha9u0VUlagt3p3WGPp6ftqvXYP3-8rZargNJU8aCNMxKFpUgKACLSCHTjFZEiDyCrMjDlJYJITSuSlExIgoKmZCsKFIglFYJi-kMPY65ndFfe7CON8pKqGv_S_9QHsVhTEieJLlHFyMqjVdkoOKdUY0wPQ8JH-TzQS8fVPOjfN_xcArfFw2UZ_7PtgeSETioGvr_8vh2uRmDfwHhlJL3</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Daimon, Shoichiro</creator><general>John Wiley & Sons Australia, Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9399-7433</orcidid></search><sort><creationdate>202010</creationdate><title>Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator</title><author>Daimon, Shoichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3677-618d72dea3ee720bc683f0aa92e8b9163d50034fdaf70ab3e8ac7bb6e033f5743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Anemia - complications</topic><topic>Anemia - drug therapy</topic><topic>Anemia - physiopathology</topic><topic>Darbepoetin alfa - therapeutic use</topic><topic>Erythropoietin - therapeutic use</topic><topic>Female</topic><topic>Hematinics - therapeutic use</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Male</topic><topic>Polyethylene Glycols - therapeutic use</topic><topic>Renal Dialysis</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daimon, Shoichiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic apheresis and dialysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daimon, Shoichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator</atitle><jtitle>Therapeutic apheresis and dialysis</jtitle><addtitle>Ther Apher Dial</addtitle><date>2020-10</date><risdate>2020</risdate><volume>24</volume><issue>5</issue><spage>602</spage><epage>606</epage><pages>602-606</pages><issn>1744-9979</issn><eissn>1744-9987</eissn><cop>Kyoto, Japan</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>32537874</pmid><doi>10.1111/1744-9987.13537</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-9399-7433</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1744-9979 |
| ispartof | Therapeutic apheresis and dialysis, 2020-10, Vol.24 (5), p.602-606 |
| issn | 1744-9979 1744-9987 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2414009559 |
| source | Wiley-Blackwell Journals; MEDLINE |
| subjects | Aged Anemia - complications Anemia - drug therapy Anemia - physiopathology Darbepoetin alfa - therapeutic use Erythropoietin - therapeutic use Female Hematinics - therapeutic use Homeostasis Humans Male Polyethylene Glycols - therapeutic use Renal Dialysis Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - therapy |
| title | Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Possible%20role%20of%20neocytolysis%20in%20anemia%20in%20hemodialysis%20patients%20with%20darbepoetin%20alfa%20or%20continuous%20erythropoietin%20receptor%20activator&rft.jtitle=Therapeutic%20apheresis%20and%20dialysis&rft.au=Daimon,%20Shoichiro&rft.date=2020-10&rft.volume=24&rft.issue=5&rft.spage=602&rft.epage=606&rft.pages=602-606&rft.issn=1744-9979&rft.eissn=1744-9987&rft_id=info:doi/10.1111/1744-9987.13537&rft_dat=%3Cproquest_cross%3E2414009559%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2414009559&rft_id=info:pmid/32537874&rfr_iscdi=true |